HBW Advisory Services LLC Buys 9,195 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• HBW Advisory Services initiated a UnitedHealth Group position by purchasing 9,195 shares valued at approximately $3.38 million. Institutional investors collectively own 87.86% of the company.
• UnitedHealth reported adjusted quarterly earnings of $4.69 per share on $112.7 billion in revenue, beating analyst expectations, and raised its 2026 adjusted earnings outlook to at least $20.50 per share.
• Analyst sentiment remains favorable, with a consensus “Moderate Buy” rating and average price target of $461.83; shares recently opened at $396.02.

HBW Advisory Services LLC purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the third quarter, according to its most recent filing with the SEC. The fund purchased 9,195 shares of the healthcare conglomerate's stock, valued at approximately $3,375,000.

Other hedge funds have also bought and sold shares of the company. Fort Washington Investment Advisors Inc. OH boosted its holdings in shares of UnitedHealth Group by 0.4% during the 3rd quarter. Fort Washington Investment Advisors Inc. OH now owns 480,050 shares of the healthcare conglomerate's stock valued at $176,217,000 after purchasing an additional 2,086 shares during the last quarter. B.A. Schrock Wealth Management Inc. purchased a new position in shares of UnitedHealth Group during the third quarter valued at about $800,000. Nolet Wealth Management LLC increased its holdings in shares of UnitedHealth Group by 9.5% in the third quarter. Nolet Wealth Management LLC now owns 781 shares of the healthcare conglomerate's stock worth $287,000 after purchasing an additional 68 shares during the last quarter. Howard Financial Services LTD. lifted its position in shares of UnitedHealth Group by 25.4% in the third quarter. Howard Financial Services LTD. now owns 1,186 shares of the healthcare conglomerate's stock worth $435,000 after buying an additional 240 shares in the last quarter. Finally, Hudock Inc. lifted its position in shares of UnitedHealth Group by 2.1% in the third quarter. Hudock Inc. now owns 2,904 shares of the healthcare conglomerate's stock worth $1,066,000 after buying an additional 60 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Insider Transactions at UnitedHealth Group

In related news, CEO Patrick Conway sold 1,169 shares of the business's stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the transaction, the chief executive officer owned 15,328 shares of the company's stock, valued at $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.19% of the stock is currently owned by insiders.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth reported adjusted earnings of $4.69 per share, above the approximately $4.14 consensus estimate, while revenue of $112.7 billion also exceeded expectations. Operating earnings increased 52% to $6.6 billion, supporting confidence in the company’s turnaround. UnitedHealth Group Shares Gap Up Following Strong Earnings
• Positive Sentiment: Management raised its 2026 adjusted earnings outlook to at least $20.50 per share, above its prior $19.50-to-$20.00 range and analyst expectations. The company also indicated that 2027 growth could be stronger than current Wall Street forecasts. UnitedHealth Group Stock Jumps on Profit Outlook Raise
• Positive Sentiment: Improved medical cost management helped the medical care ratio reach 88.4%. Investors were encouraged by better profitability across UnitedHealthcare and Optum, as well as management’s expectation that Medicaid margins will begin improving after 2026. UnitedHealth Group Gains After Q3 Beat and Higher Outlook
• Positive Sentiment: Analyst sentiment remains broadly constructive. Piper Sandler raised its target to $504 and maintained an overweight rating, while Mizuho named UNH a top healthcare pick; several targets imply substantial upside from recent levels. UnitedHealth Stock Moves Higher

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the company. HSBC raised their price target on UnitedHealth Group from $300.00 to $380.00 and gave the company a "hold" rating in a report on Monday, July 6th. Weiss Ratings raised UnitedHealth Group from a "hold (c-)" rating to a "hold (c)" rating in a report on Thursday, October 8th. New Street Research set a $402.00 target price on UnitedHealth Group in a research report on Friday, October 9th. Jefferies Financial Group raised their target price on shares of UnitedHealth Group from $401.00 to $490.00 and gave the company a "buy" rating in a report on Friday, July 17th. Finally, Wells Fargo & Company boosted their price target on shares of UnitedHealth Group from $397.00 to $485.00 and gave the stock an "overweight" rating in a research report on Monday, July 13th. Twenty investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $461.83.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $396.02 on Thursday. The company has a current ratio of 0.74, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. The stock's fifty day moving average price is $387.10 and its 200-day moving average price is $383.47. The firm has a market cap of $355.46 billion, a P/E ratio of 22.62, a P/E/G ratio of 1.41 and a beta of 0.60. UnitedHealth Group Incorporated has a 12 month low of $255.96 and a 12 month high of $461.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.14 by $0.55. The company had revenue of $112.70 billion for the quarter, compared to analysts' expectations of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The firm's quarterly revenue was down .4% on a year-over-year basis. During the same period in the prior year, the business earned $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 20.00 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were paid a dividend of $2.32 per share. The ex-dividend date was Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. UnitedHealth Group's dividend payout ratio (DPR) is currently 59.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated NYSE: UNH is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.